Variation in endoglin pathway genes is associated with preeclampsia: A case-control candidate gene association study

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Bell, Mandy J ^a,b   Roberts, James M ^a,b,c,d   Founds, Sandra A ^a,b   Jeyabalan, Arun ^b,c   Terhorst, Lauren ^a   Conley, Yvette P ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Endoglin; Genetic association study; Preeclampsia; SNP

Indexed keywords

ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; ACTIVIN RECEPTOR 2; ACVRL1 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PROTEIN SERINE THREONINE KINASE; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; PARITY; PREECLAMPSIA; SINGLE NUCLEOTIDE POLYMORPHISM; BLACK PERSON; CAUCASIAN; ETHNOLOGY; GENE EXPRESSION; GENETICS; PREGNANCY; SIGNAL TRANSDUCTION; YOUNG ADULT;

ACTIVIN RECEPTORS, TYPE II; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIGENS, CD; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION; HAPLOTYPES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84875482849     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-82     Document Type: Article

References (30)

1. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53-56. 10.1016/S0140-6736(00)03577-7, 11197372.
2. American College of Obstetricians and Gynecologists ACOG practice bulletin: diagnosis and management of preeclampsia and eclampsia (No. 33). Obstet Gynecol 2002, 99:159-167. 10.1016/S0029-7844(01)01747-1, 16175681, American College of Obstetricians and Gynecologists.
3. National Heart, Lung, and Blood Institute National High Blood Pressure Education Program Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000, 183:S1-S22. National Heart, Lung, and Blood Institute National High Blood Pressure Education Program.
4. Cheifetz S, Bellón T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992, 267:19027-19030.
5. Gougos A, Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 1990, 265:8361-8364.
6. St-Jacques S, Forte M, Lye SJ, Letarte M. Localization of endoglin, a transforming growth factor-β binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 1994, 51:405-413. 10.1095/biolreprod51.3.405, 7528549.
7. Jerkic M, Rivas-Elena JV, Prieto M, Carrón R, Sanz-Rodriguez F, Pérez-Barriocanal F, Rodríguez-Barbero A, Bernabéu C, López-Novoa JM. Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 2004, 18:609-611.
8. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005, 96:684-692. 10.1161/01.RES.0000159936.38601.22, 15718503.
9. Caniggia I, Taylor CV, Ritchie JW, Lye SJ, Letarte M. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 1997, 138:4977-4988. 10.1210/en.138.11.4977, 9348229.
10. Mano Y, Kotani T, Shibata K, Matsumura H, Tsuda H, Sumigama S, Yamamato E, Iwase A, Senga T, Kikkawa F. The loss of endoglin promotes the invasion of extravillous trophoblasts. Endocrinology 2011, 152:4386-4394. 10.1210/en.2011-1088, 21914777.
11. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009, 23:S32-S37.
12. Farina A, Sekizawa A, De Sanctis P, Purwosunu Y, Okai T, Cha DH, Kang JH, Vicenzi C, Tempesta A, Wibowo N, Valvassori L, Rizzo N. Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. Prenat Diagn 2008, 28:956-961. 10.1002/pd.2109, 18792924.
13. Farina A, Zucchini C, Sekizawa A, Purwosunu Y, de Sanctis P, Santarsiero G, Rizzo N, Morano D, Okai T. Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks. Am J Obstet Gynecol 2010, 203:1.e1-1.e7.
14. Purwosunu Y, Sekizawa A, Yoshimura S, Farina A, Wibowo N, Nakamura M, Shimizu H, Okai T. Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women. Reproductive Sciences 2009, 16:857-864. 10.1177/1933719109336622, 19474289.
15. Sekizawa A, Purwosunu Y, Farina A, Shimizu H, Nakamura M, Wibowo N, Rizzo N, Okai T. Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation. Br J Obstet Gynaecol 2010, 117:557-564.
16. Sitras V, Paulssen RH, Gronaas H, Leirvik J, Hanssen TA, Vartun A, Acharya G. Differential placental gene expression in severe preeclampsia. Placenta 2009, 30:424-433. 10.1016/j.placenta.2009.01.012, 19249095.
17. Tsai S, Hardison NE, James AH, Motsinger-Reif AA, Bischoff SR, Thames BH, Piedrahita JA. Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signaling pathways. Placenta 2011, 32:175-182. 10.1016/j.placenta.2010.11.014, 3039036, 21183218.
18. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Karumanchi SA. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649. 10.1038/nm1429, 16751767.
19. Kaitu'u-Lino T, Palmer KR, Whitehead CL, Williams E, Lappas M, Tong S. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin. Am J Pathol 2012, 180:888-894. 10.1016/j.ajpath.2011.11.014, 22296769.
20. Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk developing preeclampsia. Hypertension 2007, 50:137-142. 10.1161/HYPERTENSIONAHA.107.087700, 17515455.
21. Lind T, Godfrey KA, Otun H, Philips PR. Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol 1984, 91:128-132. 10.1111/j.1471-0528.1984.tb05895.x, 6696858.
22. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, Diekhans M, Dreszer TR, Giardine BM, Harte RA, Hillman-Jackson J, Hsu F, Kirkup V, Kuhn RM, Learned K, Li CH, Meyer LR, Pohl A, Raney BJ, Rosenbloom KR, Smith KE, Haussler D, Kent WJ. The UCSC genome browser database: update 2011. Nucleic Acids Res 2011, 39:D876-D882. 10.1093/nar/gkq963, 3242726, 20959295.
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
24. Botella LM, Sánchez-Elsner T, Rius C, Corbí A, Bernabéu C. Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-β stimulation. J Biol Chem 2001, 276:34486-34494. 10.1074/jbc.M011611200, 11432852.
25. Guerrero-Esteo M, Sánchez-Elsner T, Letamendia A, Bernabéu C. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem 2002, 277:29197-29209. 10.1074/jbc.M111991200, 12015308.
26. Bosler AD, Richards J, George C, Godmilow L, Ganguly A. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): Correlation of genotype with phenotype. Hum Mut 2006, 27:667-675. 10.1002/humu.20342, 16752392.
27. Hawinkles L, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, Sier CF, ten Dijke P. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 2010, 70:4141-4150. 10.1158/0008-5472.CAN-09-4466, 20424116.
28. Ríus C, Smith JD, Almendro N, Langa C, Botella LM, Marchuk DA, Vary CP, Bernabéu C. Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1. Blood 1998, 92:4677-4690.
29. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P. Transforming growth factor-β1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A 2000, 97:3479-3484. 16265, 10725360.
30. Srinivas SK, Morrison AC, Andrela CM, Elovitz MA. Allelic variations in angiogenic pathway genes are associated with preeclampsia. Am J Obstet Gynecol 2010, 202:445.e1-11.